Serena Williams and Weight Loss Drugs: Answers to Every Question About Her Health, Medication, and Tennis Future

Uncover in-depth coverage surrounding Serena Williams and Weight Loss Drugs: Answers to Every Question About Her Health, Medication, and Tennis Future.

Q1: Has Serena Williams ever publicly stated that she uses Ozempic or Zepbound?
A1: No. Williams has never confirmed, endorsed, or stated that she takes Ozempic, Zepbound, Wegovy, or any other GLP-1 receptor agonist for weight management or diabetes care.

Q2: Are GLP-1 receptor agonists banned by the World Anti-Doping Agency (WADA)?
A2: No. Semaglutide and tirzepatide do not appear on WADA’s prohibited list. They are permitted in competition because they offer no anabolic, endurance-boosting, or acute performance-enhancing benefits for elite sports.

Q3: Would using a weight loss drug help an athlete make a successful tennis comeback?
A3: It is unlikely. These medications suppress appetite and can cause lean muscle mass loss alongside fatigue, gastrointestinal distress, and dehydration, side effects that directly impair the endurance and explosive power required for top-tier tennis competition.

Q4: Why did rumors linking Serena Williams to weight loss drugs start circulating?
A4: The rumors arose from social media scrutiny following her public appearances after her second pregnancy. Observers conflated natural lifestyle shifts and post-retirement workout changes with the broader celebrity trend toward prescription metabolic drugs.